Correlation Between Apellis Pharmaceuticals and 4D Molecular
Can any of the company-specific risk be diversified away by investing in both Apellis Pharmaceuticals and 4D Molecular at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apellis Pharmaceuticals and 4D Molecular into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apellis Pharmaceuticals and 4D Molecular Therapeutics, you can compare the effects of market volatilities on Apellis Pharmaceuticals and 4D Molecular and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apellis Pharmaceuticals with a short position of 4D Molecular. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apellis Pharmaceuticals and 4D Molecular.
Diversification Opportunities for Apellis Pharmaceuticals and 4D Molecular
0.93 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between Apellis and FDMT is 0.93. Overlapping area represents the amount of risk that can be diversified away by holding Apellis Pharmaceuticals and 4D Molecular Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 4D Molecular Therapeutics and Apellis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apellis Pharmaceuticals are associated (or correlated) with 4D Molecular. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 4D Molecular Therapeutics has no effect on the direction of Apellis Pharmaceuticals i.e., Apellis Pharmaceuticals and 4D Molecular go up and down completely randomly.
Pair Corralation between Apellis Pharmaceuticals and 4D Molecular
Given the investment horizon of 90 days Apellis Pharmaceuticals is expected to generate 1.17 times more return on investment than 4D Molecular. However, Apellis Pharmaceuticals is 1.17 times more volatile than 4D Molecular Therapeutics. It trades about 0.19 of its potential returns per unit of risk. 4D Molecular Therapeutics is currently generating about -0.14 per unit of risk. If you would invest 2,734 in Apellis Pharmaceuticals on August 28, 2024 and sell it today you would earn a total of 457.00 from holding Apellis Pharmaceuticals or generate 16.72% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Apellis Pharmaceuticals vs. 4D Molecular Therapeutics
Performance |
| Timeline |
| Apellis Pharmaceuticals |
| 4D Molecular Therapeutics |
Apellis Pharmaceuticals and 4D Molecular Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Apellis Pharmaceuticals and 4D Molecular
The main advantage of trading using opposite Apellis Pharmaceuticals and 4D Molecular positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apellis Pharmaceuticals position performs unexpectedly, 4D Molecular can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 4D Molecular will offset losses from the drop in 4D Molecular's long position.| Apellis Pharmaceuticals vs. Eliem Therapeutics | Apellis Pharmaceuticals vs. HCW Biologics | Apellis Pharmaceuticals vs. Scpharmaceuticals | Apellis Pharmaceuticals vs. Milestone Pharmaceuticals |
| 4D Molecular vs. Eliem Therapeutics | 4D Molecular vs. HCW Biologics | 4D Molecular vs. Scpharmaceuticals | 4D Molecular vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Transaction History View history of all your transactions and understand their impact on performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |